Home2026May

Monthly Archives: May, 2026

Inhibrx provides clinical update on ozekibart in late line colorectal cancer

Louise Wilson-English -
Inhibrx Biosciences, a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, has released updated interim data from its phase 1/2 study evaluating...

US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants

Louise Wilson-English -
The global health innovative technology (GHIT) fund has announced a total investment of approximately JPY 1.37 billion (US$ 8.5 million) in five R&D projects...

Positive phase 1 data for RAG-17 in amyotrophic lateral sclerosis patients with mutations in the superoxide dismutase 1 gene

Louise Wilson-English -
Ractigen Therapeutics, a clinical-stage biopharmaceutical company focused on developing next-generation RNA-based medicines, has announced positive preliminary data from the single ascending dose (SAD) phase...

New non-compromise early-phase progression accelerator launched

Louise Wilson-English -
Carbogen AMCIS introduces Sprint for early-phase development, a new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour. Sprint has been designed to...

AstraZeneca to seek accelerated approval of Ultomirisin in immunoglobulin A nephropathy on phase 3 data

Louise Wilson-English -
AstraZeneca plans to seek accelerated approval of Ultomirisin kidney disease after the drug showed benefit after just 34 weeks, meeting its first primary endpoint. In...

Tenvie doses first subject in phase 1 TNV108 trial for peripheral neuropathies

Louise Wilson-English -
Tenvie Therapeutics has dosed the first participant in its phase 1 clinical trial of TNV108 to treat peripheral neuropathies. The trial will assess the tolerability...

Roche reports phase 3 study results for myelin oligodendrocyte glycoprotein antibody-associated disease

Louise Wilson-English -
Roche has reported new findings from the phase 3 meteoroid trial of Enspryng (satralizumab) in adults and adolescents with myelin oligodendrocyte glycoprotein antibody-associated disease...

Most Read